Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit
Allergan Aesthetics, an AbbVie company, will lead R&D programming on skin longevity, aging biology and exosome science at the 2026 Science of Skin Summit, held Sept. 17-20 in Austin, Texas. SkinMedica's R&D panel will introduce the FACTS Principles, a science-based framework intended to standardize evaluation of exosome-based skincare across formulation and stability, analysis, clinical studies, cellular origin and safety.
Key figures
- Clinical studies
- more than 200
- Years skincare research
- more than 25
- Peer reviewed publications
- 100
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.